Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Nortriptyline hydrochloride
Necessity Supplies Ltd
N06AA10
Nortriptyline hydrochloride
25mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 04030100
_S1243 LEAFLET Allegron 20171106 _ PATIENT INFORMATION LEAFLET ALLEGRON 25MG TABLETS (NORTRIPTYLINE HYDROCHLORIDE) Your medicine is known as Allegron 25mg Tablets but will be referred to as Allegron tablets throughout the following leaflet. Information for other strengths of Allegron tablets (Allegron 10mg Tablets) also may be present in this leaflet. READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Allegron tablets are and what they are used for 2. What you need to know before you take Allegron tablets 3. How to take Allegron tablets 4. Possible side effects 5. How to store Allegron tablets 6. Contents of the pack and other information 1. WHAT ALLEGRON TABLETS ARE AND WHAT THEY ARE USED FOR Allegron tablets contain the active ingredient nortriptyline hydrochloride, which is a tricyclic antidepressant. Allegron tablets relieve the symptoms of depression. Allegron tablets may also be used for the treatment of bed-wetting in children 6 years and older. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE ALLEGRON TABLETS DO NOT TAKE ALLEGRON TABLETS If you are allergic to nortriptyline hydrochloride or any of the other ingredients of this medicine (listed in section 6). An allergic reaction may include rash, itching, difficulty breathing or swelling of the face, lips, throat or tongue; If you have had a recent heart attack or heartbeat disorder; If you have severe liver disease; If you suffer from mania (abnormally raised mood); If you are breast-feeding; If the child is under 6 Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Allegron Tablets 25 mg Nortriptyline 25 mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION ALLEGRON TABLETS 25 MG/ NORTRIPTYLINE 25 MG TABLETS: Tablets each containing Nortriptyline Hydrochloride EP equivalent to 25mg nortriptyline base. Tablets are orange, scored and have a diameter of 8mm. They are marked ´KING’. Excipient(s) with known effect Lactose Sunset yellow (E110) For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Allegron Tablets 25 mg/ Nortriptyline 25 mg Tablets: Tablet. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Nortriptyline is indicated for the relief of symptoms of depression. It may also be used for the treatment of some cases of nocturnal enuresis. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Adults:_ The usual adult dose is 25mg three or four times daily. Dosage should begin at a low level and be increased as required. Alternatively, the total daily dose may be given once a day. When doses above 100mg daily are administered, plasma levels of nortriptyline should be monitored and maintained in the optimum range of 50 to 150ng/ml. Doses above 150mg per day are not recommended. Lower than usual dosages are recommended for elderly patients and adolescents. Lower dosages are also recommended for outpatients than for hospitalised patients who will be under close supervision. The physician should initiate dosage at a low level and increase it gradually, noting carefully the clinical response and any evidence of intolerance. Following remission, maintenance medication may be required for a longer period of time at the lowest dose that will maintain remission. If a patient develops minor side-effects, the dosage should be reduced. The drug should be discontinued promptly if adverse effects of a serious nature or allergic manifestations occur. _ _ _The elderly:_ 30 to 50mg/day in divided doses Read the complete document